| ST3GAL3 |
Homo sapiens |
|
ST3GAL3 is differentially expressed in 37 experiments [55 up/49 dn]: 15 organism parts: skeletal muscle [2 up/1 dn], white blood cells [0 up/1 dn], ...; 15 disease states: normal [2 up/3 dn], breast carcinoma [1 up/1 dn], ...; 11 cell types, 14 cell lines, 8 compound treatments and 9 other conditions. |
| RP11-7O11.1-006, RP11-7O11.1-007, SIAT6, ST3GalIII, ST3GAL3 |
|
st3gal3 (Danio rerio)
St3gal3 (Mus musculus)
SIAT6_RAT (Rattus norvegicus)
(Compare orthologs)
|
|
|
| Glycosyl transferase, family 29, Sialyltransferase |
|
|
| N-acetyllactosaminide alpha-2,3-sialyltransferase activity, extracellular region, integral to Golgi membrane, sialyltransferase activity, transferase activity, transferring glycosyl groups |
|
|
|
Q11203
Q5T4W8
Q5T4Y1
Q96L53
|
|
|
|
ENSG00000126091
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
Stromal cell
|
Cell type |
|
|
Skeletal muscle
|
Organism part |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
Epithelial cell
|
Cell type |
|
|
None
|
Compound treatment |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Breast carcinoma
|
Disease state |
|
|
N/a
|
Test result |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
White blood cells
|
Organism part |
|
|
Macaca mulatta
|
Organism |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
Spermatid
|
Cell type |
|
|
Homo sapiens
|
Organism |
|
|
Not applicable
|
Histology |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
PC3
|
Cell line |
|
|
Spermatocyte
|
Cell type |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Testis
|
Organism part |
|
|
Pan troglodytes
|
Organism |
|
|
Cartilage
|
Organism part |
|
|
Seminiferous tubule
|
Organism part |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Uninfected
|
Infection |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
Tumor
|
Organism part |
|
|
Grade IV
|
Tumor grading |
|
|
Glioblastoma
|
Disease state |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
Vasectomized
|
Clinical history |
|
|
HeLa
|
Cell line |
|
|
AGS
|
Cell line |
|
|
Media only
|
Growth condition |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
Superior cervical ganglion
|
Organism part |
|
|
MCF-7
|
Cell line |
|
|
10 ng/ml LPS in media
|
Growth condition |
|
|
A549
|
Cell line |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Leydig cell
|
Cell type |
|
|
Cryptorchidism
|
Clinical history |
|
|
TMK1
|
Cell line |
|
|
Ischemic cardiomyopathy
|
Disease state |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Grade II
|
Tumor grading |
|
|
Breast cancer
|
Disease state |
|
|
Cervical cancer
|
Disease state |
|
|
IL-22
|
Compound treatment |
|
|
Endothelial cell
|
Cell type |
|
|
Skin
|
Organism part |
|
|
Wild_type
|
Genotype |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
MDA-MB-231
|
Cell line |
|
|
Normal
|
Histology |
|
|
Gastric adenocarcinoma
|
Disease state |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
XBP1 overexpression
|
Genotype |
|
|
Adipose-derived stem cell
|
Cell type |
|
|
Met5A
|
Cell line |
|
|
Caudate nucleus
|
Organism part |
|
|
Oligodendroglioma
|
Disease state |
|
|
SNU5
|
Cell line |
|
|
Hippocampus
|
Organism part |
|
|
Granulocyte-colony stimulating...
|
Compound treatment |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Cystic change
|
Histology |
|
|
Pancreas
|
Organism part |
|
|
IL-20
|
Compound treatment |
|
|
CD14+ monocyte
|
Cell type |
|
|
YCC1
|
Cell line |
|
|
Atrioventricular node
|
Organism part |
|
|
Johnsen score count 7: many ea...
|
Histology |
|
|
|
|
|
Processing time: 0.12 secs.